(4R)-8-ethynyl-6-(2-fluorophenyl)-N,N,4-trimethyl-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxamide

ID: ALA4537552

PubChem CID: 130439778

Max Phase: Preclinical

Molecular Formula: C23H19FN4O

Molecular Weight: 386.43

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C#Cc1ccc2c(c1)C(c1ccccc1F)=N[C@H](C)c1c(C(=O)N(C)C)ncn1-2

Standard InChI:  InChI=1S/C23H19FN4O/c1-5-15-10-11-19-17(12-15)20(16-8-6-7-9-18(16)24)26-14(2)22-21(23(29)27(3)4)25-13-28(19)22/h1,6-14H,2-4H3/t14-/m1/s1

Standard InChI Key:  LNPOWXXHIUMIKI-CQSZACIVSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   21.6541  -25.0976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6530  -25.9130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3569  -26.3220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3551  -24.6929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0627  -25.9140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0596  -25.0940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7105  -26.4273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5135  -26.2369    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.8656  -25.4908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6980  -24.5773    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.5084  -24.7514    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9202  -24.0385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3710  -23.4214    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.6173  -23.7570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5381  -27.2211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9533  -26.3209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2494  -26.7248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7291  -24.0370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1391  -24.7398    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.1364  -23.3285    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.7644  -27.4653    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5918  -28.2583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1934  -28.8054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9703  -28.5540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1391  -27.7616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9163  -27.5090    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   25.6828  -25.4870    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.9536  -23.3269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7264  -22.6216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  5  2  0
  6  4  2  0
  4  1  1  0
  5  6  1  0
  6 10  1  0
  5  7  1  0
  7  8  2  0
 11  9  1  0
  8  9  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 10  1  0
  7 15  1  0
 16 17  3  0
  2 16  1  0
 12 18  1  0
 18 19  2  0
 18 20  1  0
 15 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 15  1  0
 25 26  1  0
  9 27  1  1
 20 28  1  0
 20 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4537552

    ---

Associated Targets(Human)

GABRA1 Tclin GABA receptor alpha-1 subunit (399 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABRA2 Tclin GABA receptor alpha-2 subunit (271 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABRA3 Tclin GABA receptor alpha-3 subunit (187 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABRA5 Tclin GABA receptor alpha-5 subunit (699 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 386.43Molecular Weight (Monoisotopic): 386.1543AlogP: 3.61#Rotatable Bonds: 2
Polar Surface Area: 50.49Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.76CX LogP: 3.50CX LogD: 3.50
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.63Np Likeness Score: -1.11

References

1. Maramai S, Benchekroun M, Ward SE, Atack JR..  (2020)  Subtype Selective γ-Aminobutyric Acid Type A Receptor (GABAAR) Modulators Acting at the Benzodiazepine Binding Site: An Update.,  63  (7): [PMID:31738537] [10.1021/acs.jmedchem.9b01312]

Source